ALK and squamous cell lung carcinoma: For example, kinases ALK, PRKD1, MYLK, CAMKK1, CAMKK2, DAPK3, EGFR, GAK, DCAMKL1 emerge to be more relevant for the lung squamous cell carcinoma (few cell lines originating from this diseased tissue) while kinases MRCKA, MRCKB, DMPK2, HIPK4, CDK2, CDK8, CDK11, PIK3CA, NEK5, ERK3, and CSNK1D appear to be not affected by compounds causing cell death in the same cell lines.